Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -235.27% | -34.06% | 8.42% | -44.53% | -183.48% |
| Total Depreciation and Amortization | 34.21% | 78.13% | -3.03% | 0.00% | 94.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,226.23% | 62.37% | -85.29% | 60.61% | 47,294.12% |
| Change in Net Operating Assets | -1,867.44% | 1,452.24% | -108.93% | 278.27% | -405.07% |
| Cash from Operations | -274.69% | -17.41% | -255.98% | 24.78% | -33.82% |
| Capital Expenditure | -37.54% | -540.43% | -- | 100.00% | 91.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 23.51% | -- |
| Cash from Investing | -37.54% | -540.43% | 84.79% | 24.26% | -750.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -100.00% | 103.81% |
| Issuance of Common Stock | -99.93% | -35.52% | -31.77% | 200.02% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 267.41% | 19.13% | 613.57% | 157.73% | -- |
| Cash from Financing | -29.75% | -28.96% | -23.46% | 225.13% | 1,441.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 111.36% | -246.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -958.90% | -68.38% | -53.14% | 430.85% | 241.46% |